ScholarIQanswers from OpenAlex & ORCID
Takeshi Iwatsubo
ResearcherPublications, citations & collaboration network
Takeshi Iwatsubo is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Takeshi Iwatsubo have?
ScholarIQindexed works
Takeshi Iwatsubo has 711 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Takeshi Iwatsubo have?
ScholarIQcitation count
Takeshi Iwatsubo has 74,724 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Takeshi Iwatsubo?
ScholarIQh-index
Takeshi Iwatsubo has an h-index of 115 in OpenAlex.
What is the i10-index of Takeshi Iwatsubo?
ScholarIQi10-index
Takeshi Iwatsubo has an i10-index of 395 in OpenAlex.
What is the ORCID of Takeshi Iwatsubo?
ScholarIQorcid
The ORCID for Takeshi Iwatsubo is on the source record.
What is the OpenAlex record for Takeshi Iwatsubo?
ScholarIQopenalex
The OpenAlex for Takeshi Iwatsubo is on the source record.
What are the most-cited papers on Takeshi Iwatsubo?
ScholarIQmost cited works
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling, Paul Aisen, Laurel Beckett, David A. Bennett, Suzanne Craft, Anne M. Fagan, Takeshi Iwatsubo, Clifford R. Jack, Jeffrey Kaye, Thomas J. Montine, Denise C. Park, Eric M. Reiman, Christopher C. Rowe, Eric Siemers, Yaakov Stern, Kristine Yaffe, María C. Carrillo, Bill Thies, Marcelle Morrison‐Bogorad, Molly V. Wagster, Creighton H. Phelps
Lecanemab in Early Alzheimer’s Disease
Christopher H. van Dyck, Chad J. Swanson, Paul Aisen, Randall J. Bateman, Christopher Chen, Michelle Gee, Michio Kanekiyo, David Li, Larisa Reyderman, Sharon Cohen, Lutz Froelich, Sadao Katayama, Marwan Sabbagh, Bruno Vellas, David Watson, Shobha Dhadda, Michael C. Irizarry, Lynn D. Kramer, Takeshi Iwatsubo
Diagnosis and management of dementia with Lewy bodies
Ian G. McKeith, Dennis W. Dickson, James Lowe, Murat Emre, John T. O’Brien, Howard Feldman, Jeffrey L. Cummings, John E. Duda, Carol F. Lippa, Elaine K. Perry, Dag Aarsland, Heii Arai, Clive Ballard, Bradley F. Boeve, David J. Burn, Durval C. Costa, Teodoro del Ser, Bruno Dubois, Douglas Galasko, Serge Gauthier, Christopher G. Goetz, Estrella Gómez‐Tortosa, Glenda M. Halliday, Lawrence A. Hansen, John Hardy, Takeshi Iwatsubo, Raj N. Kalaria, Daniel Kaufer, Rose Anne Kenny, Amos D. Korczyn, Kenji Kosaka, V.M.Y. Lee, Andrew J. Lees, Irene Litvan, Elisabet Londos, Oscar L. López, Satoshi Minoshima, Y Mizuno, J. A. Molina, Elizabeta B. Mukaetova‐Ladinska, Florence Pasquier, R. H. Perry, Jörg B. Schulz, John Q. Trojanowski, Masahito Yamada
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Peter T. Nelson, Irina Alafuzoff, Eileen H. Bigio, Constantin Bouras, Heiko Braak, Nigel J. Cairns, Rudolph J. Castellani, Barbara J. Crain, Peter Davies, Kelly Del Tredici, Charles Duyckaerts, Matthew P. Frosch, Vahram Haroutunian, Patrick R. Hof, Christine M. Hulette, Bradley T. Hyman, Takeshi Iwatsubo, K. A. Jellinger, Gregory A. Jicha, Enikò Kövari, Walter A. Kukull, James B. Leverenz, Seth Love, Ian R. Mackenzie, David Mann, Eliezer Masliah, Ann C. McKee, Thomas J. Montine, John C. Morris, Julie A. Schneider, Joshua A. Sonnen, Dietmar Rudolf Thal, John Q. Trojanowski, Juan C. Troncoso, Thomas Wısnıewskı, Randall L. Woltjer, Thomas G. Beach
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Rema Raman, Xiaoying Sun, Paul Aisen, Eric Siemers, Hong Liu‐Seifert, Richard C. Mohs